$662.79 Million in Sales Expected for HB Fuller Co (FUL) This Quarter

Analysts predict that HB Fuller Co (NYSE:FUL) will report $662.79 million in sales for the current fiscal quarter, according to Zacks. Three analysts have issued estimates for HB Fuller’s earnings, with the highest sales estimate coming in at $716.87 million and the lowest estimate coming in at $601.80 million. HB Fuller posted sales of $503.32 million during the same quarter last year, which would indicate a positive year over year growth rate of 31.7%. The business is expected to issue its next quarterly earnings results on Wednesday, April 4th.

According to Zacks, analysts expect that HB Fuller will report full year sales of $662.79 million for the current year, with estimates ranging from $3.00 billion to $3.14 billion. For the next fiscal year, analysts anticipate that the business will post sales of $3.21 billion per share, with estimates ranging from $3.11 billion to $3.29 billion. Zacks’ sales calculations are a mean average based on a survey of sell-side analysts that follow HB Fuller.

HB Fuller (NYSE:FUL) last announced its earnings results on Tuesday, January 23rd. The specialty chemicals company reported $0.75 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.84 by ($0.09). HB Fuller had a return on equity of 12.83% and a net margin of 2.53%. The business had revenue of $678.20 million for the quarter, compared to analyst estimates of $613.58 million.

Several brokerages have recently weighed in on FUL. Zacks Investment Research raised shares of HB Fuller from a “hold” rating to a “buy” rating and set a $61.00 price target on the stock in a research report on Tuesday, January 30th. Citigroup cut shares of HB Fuller from a “buy” rating to a “neutral” rating and set a $60.00 price target on the stock. in a research report on Tuesday, October 31st. Longbow Research raised shares of HB Fuller from a “neutral” rating to a “buy” rating and set a $60.00 price target on the stock in a research report on Tuesday, February 6th. ValuEngine lowered shares of HB Fuller from a “buy” rating to a “hold” rating in a report on Friday, November 10th. Finally, Deutsche Bank upgraded shares of HB Fuller from a “hold” rating to a “buy” rating and boosted their price objective for the company from $60.00 to $62.00 in a report on Thursday, January 25th. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and five have issued a buy rating to the company. The company presently has a consensus rating of “Hold” and a consensus price target of $61.50.

A number of large investors have recently modified their holdings of the business. Stanley Laman Group Ltd. increased its stake in HB Fuller by 4.0% during the fourth quarter. Stanley Laman Group Ltd. now owns 91,503 shares of the specialty chemicals company’s stock worth $4,929,000 after purchasing an additional 3,539 shares during the period. Penn Capital Management Co. Inc. increased its stake in HB Fuller by 302.8% during the fourth quarter. Penn Capital Management Co. Inc. now owns 66,731 shares of the specialty chemicals company’s stock worth $3,713,000 after purchasing an additional 50,166 shares during the period. UBS Asset Management Americas Inc. increased its stake in shares of HB Fuller by 7.1% during the fourth quarter. UBS Asset Management Americas Inc. now owns 42,268 shares of the specialty chemicals company’s stock worth $2,277,000 after buying an additional 2,807 shares during the period. BlackRock Inc. increased its stake in shares of HB Fuller by 1.1% during the fourth quarter. BlackRock Inc. now owns 6,399,023 shares of the specialty chemicals company’s stock worth $344,715,000 after buying an additional 69,226 shares during the period. Finally, Rhumbline Advisers increased its stake in shares of HB Fuller by 17.9% during the fourth quarter. Rhumbline Advisers now owns 134,817 shares of the specialty chemicals company’s stock worth $7,263,000 after buying an additional 20,479 shares during the period. Institutional investors own 92.89% of the company’s stock.

HB Fuller (NYSE:FUL) opened at $49.00 on Friday. The company has a current ratio of 2.27, a quick ratio of 1.56 and a debt-to-equity ratio of 2.30. The firm has a market cap of $2,550.00, a PE ratio of 43.75, a PEG ratio of 1.00 and a beta of 1.57. HB Fuller has a 1 year low of $47.36 and a 1 year high of $58.74.

The firm also recently declared a quarterly dividend, which will be paid on Thursday, February 15th. Shareholders of record on Thursday, February 1st will be paid a dividend of $0.15 per share. The ex-dividend date is Wednesday, January 31st. This represents a $0.60 dividend on an annualized basis and a yield of 1.22%. HB Fuller’s dividend payout ratio (DPR) is presently 53.57%.

ILLEGAL ACTIVITY WARNING: “$662.79 Million in Sales Expected for HB Fuller Co (FUL) This Quarter” was first posted by American Banking News and is the property of of American Banking News. If you are viewing this piece of content on another domain, it was illegally copied and republished in violation of US & international copyright laws. The original version of this piece of content can be viewed at https://www.americanbankingnews.com/2018/02/11/662-79-million-in-sales-expected-for-hb-fuller-co-ful-this-quarter.html.

About HB Fuller

H.B. Fuller Company is a formulator, manufacturer and marketer of adhesives, sealants and other specialty chemical products. The Company’s segments include Americas Adhesives, Europe, India, Middle East and Africa (EIMEA), Asia Pacific, Construction Products and Engineering Adhesives. The Americas Adhesives, EIMEA and Asia Pacific operating segments produce and supply industrial adhesives products for applications in various markets, including durable assembly, nonwoven and hygiene, and textile.

Get a free copy of the Zacks research report on HB Fuller (FUL)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for HB Fuller (NYSE:FUL)

Receive News & Ratings for HB Fuller Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HB Fuller and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply